JP4550273B2 - アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用 - Google Patents

アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用 Download PDF

Info

Publication number
JP4550273B2
JP4550273B2 JP2000520798A JP2000520798A JP4550273B2 JP 4550273 B2 JP4550273 B2 JP 4550273B2 JP 2000520798 A JP2000520798 A JP 2000520798A JP 2000520798 A JP2000520798 A JP 2000520798A JP 4550273 B2 JP4550273 B2 JP 4550273B2
Authority
JP
Japan
Prior art keywords
methyl
dideoxy
ketolide
group
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000520798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001523644A5 (cg-RX-API-DMAC7.html
JP2001523644A (ja
Inventor
プティ フランシス
ヴァシュロン フランソワ
Original Assignee
アベンティス・ファーマ・ソシエテ・アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アベンティス・ファーマ・ソシエテ・アノニム filed Critical アベンティス・ファーマ・ソシエテ・アノニム
Publication of JP2001523644A publication Critical patent/JP2001523644A/ja
Publication of JP2001523644A5 publication Critical patent/JP2001523644A5/ja
Application granted granted Critical
Publication of JP4550273B2 publication Critical patent/JP4550273B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2000520798A 1997-11-17 1998-11-16 アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用 Expired - Fee Related JP4550273B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
FR97/14358 1997-11-17
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (3)

Publication Number Publication Date
JP2001523644A JP2001523644A (ja) 2001-11-27
JP2001523644A5 JP2001523644A5 (cg-RX-API-DMAC7.html) 2006-01-12
JP4550273B2 true JP4550273B2 (ja) 2010-09-22

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520798A Expired - Fee Related JP4550273B2 (ja) 1997-11-17 1998-11-16 アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用

Country Status (35)

Country Link
US (1) US20080139489A1 (cg-RX-API-DMAC7.html)
EP (1) EP1030673B1 (cg-RX-API-DMAC7.html)
JP (1) JP4550273B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010032130A (cg-RX-API-DMAC7.html)
CN (1) CN1286633A (cg-RX-API-DMAC7.html)
AP (1) AP1196A (cg-RX-API-DMAC7.html)
AR (1) AR014119A1 (cg-RX-API-DMAC7.html)
AT (1) ATE271875T1 (cg-RX-API-DMAC7.html)
AU (1) AU744419B2 (cg-RX-API-DMAC7.html)
BG (1) BG104427A (cg-RX-API-DMAC7.html)
BR (1) BR9814199A (cg-RX-API-DMAC7.html)
CA (1) CA2312021C (cg-RX-API-DMAC7.html)
DE (1) DE69825308T2 (cg-RX-API-DMAC7.html)
DZ (1) DZ2654A1 (cg-RX-API-DMAC7.html)
EA (1) EA003322B1 (cg-RX-API-DMAC7.html)
EE (1) EE04095B1 (cg-RX-API-DMAC7.html)
ES (1) ES2224446T3 (cg-RX-API-DMAC7.html)
FR (1) FR2771008B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20032968B (cg-RX-API-DMAC7.html)
HR (1) HRP20000314A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0004507A3 (cg-RX-API-DMAC7.html)
ID (1) ID24940A (cg-RX-API-DMAC7.html)
IL (1) IL136149A0 (cg-RX-API-DMAC7.html)
MA (1) MA26566A1 (cg-RX-API-DMAC7.html)
NO (1) NO20002435L (cg-RX-API-DMAC7.html)
NZ (1) NZ504305A (cg-RX-API-DMAC7.html)
OA (1) OA11411A (cg-RX-API-DMAC7.html)
PL (1) PL340373A1 (cg-RX-API-DMAC7.html)
SK (1) SK7042000A3 (cg-RX-API-DMAC7.html)
TN (1) TNSN98206A1 (cg-RX-API-DMAC7.html)
TR (1) TR200001384T2 (cg-RX-API-DMAC7.html)
TW (1) TW472061B (cg-RX-API-DMAC7.html)
WO (1) WO1999025365A1 (cg-RX-API-DMAC7.html)
YU (1) YU29600A (cg-RX-API-DMAC7.html)
ZA (1) ZA9810357B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
HUP0300370A3 (en) 2000-04-04 2005-07-28 Smithkline Beecham Plc 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
YU29600A (sh) 2003-02-28
NO20002435L (no) 2000-07-07
WO1999025365A1 (fr) 1999-05-27
BG104427A (en) 2001-02-28
CA2312021A1 (fr) 1999-05-27
BR9814199A (pt) 2000-09-26
EP1030673A1 (fr) 2000-08-30
DE69825308D1 (de) 2004-09-02
EE200000244A (et) 2001-06-15
DE69825308T2 (de) 2005-08-04
AU744419B2 (en) 2002-02-21
DZ2654A1 (fr) 2003-03-22
SK7042000A3 (en) 2000-12-11
JP2001523644A (ja) 2001-11-27
TNSN98206A1 (fr) 2005-03-15
AU1242599A (en) 1999-06-07
HUP0004507A3 (en) 2001-12-28
CN1286633A (zh) 2001-03-07
AP2000001825A0 (en) 2000-06-30
ES2224446T3 (es) 2005-03-01
GEP20032968B (en) 2003-05-27
KR20010032130A (ko) 2001-04-16
AR014119A1 (es) 2001-02-07
EA003322B1 (ru) 2003-04-24
TW472061B (en) 2002-01-11
ZA9810357B (en) 1999-11-12
TR200001384T2 (tr) 2001-06-21
EP1030673B1 (fr) 2004-07-28
PL340373A1 (en) 2001-01-29
HRP20000314A2 (en) 2001-02-28
CA2312021C (fr) 2008-08-26
US20080139489A1 (en) 2008-06-12
EE04095B1 (et) 2003-08-15
HUP0004507A1 (hu) 2001-05-28
AP1196A (en) 2003-08-18
EA200000531A1 (ru) 2000-10-30
NZ504305A (en) 2002-11-26
FR2771008B1 (fr) 2000-04-28
ATE271875T1 (de) 2004-08-15
IL136149A0 (en) 2001-05-20
ID24940A (id) 2000-08-31
MA26566A1 (fr) 2004-12-20
OA11411A (fr) 2004-04-20
FR2771008A1 (fr) 1999-05-21

Similar Documents

Publication Publication Date Title
US20080139489A1 (en) Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
CN106456795A (zh) 靶向治疗学
EA003510B1 (ru) Ингибиторы фарнезилпротеинтрансферазы, применяемые для лечения артропатий
JPH09176182A (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
US4847281A (en) Method of medical treatment of addiction
JP2000505469A (ja) 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用
HU211666A9 (en) Antiviral compounds
JP2001508400A (ja) アセチルコリンエステラーゼ阻害剤および鎮痛剤としてのイサチン誘導体
WO1993023047A1 (en) Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
JPH04360833A (ja) 1,4−ジヒドロピリジン誘導体を含有する製剤
JP4573925B2 (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
EP0866706A1 (en) Treatment of traumatic brain injury
DE69723873T2 (de) Kristallines pharmazeutisches produkt
JPH0680569A (ja) 血小板凝集阻害剤
JPH0530814B2 (cg-RX-API-DMAC7.html)
WO2005021481A1 (en) N, n’-dibenzyl ethylenediamine salt pf 2-(alpha-hidroxypentyl) benzoic acid and its preparing process and usage
HU200098B (en) Process for producing pharmaceutical compositions for treating peptic ulcers
JP4426654B2 (ja) 免疫調節用医薬組成物
CZ20001798A3 (cs) Použití ketolidů pro přípravu farmaceutických prostředků určených pro předcházení arteriálním trombotickým komplikacím spojeným s atherosklerosou
MXPA00004771A (en) Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
HU208972B (en) Process for producing cristalline hydrochloride of new beta-lactame antibioticum and pharmaceutical preparations containing them
BRPI0611096A2 (pt) (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)a mino]-1,3-tiazol-4(5h)-ona
CZ12566U1 (cs) Amlodipinhemimaleát a farmaceutický prostředek
JPH0788304B2 (ja) 高アンモニア血症治療剤
HUT52384A (en) Process for producing pharmaceutical compositions comprising dianhydrohexitol acyl derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090918

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090918

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20090918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090918

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100608

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100708

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130716

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees